Disclosures for "Human Genetic Prioritization of Coagulation Cascade Proteins as Targets for Preventing Ischemic Stroke"
-
Dr. Daghlas has nothing to disclose.
-
Dr. Karhunen has nothing to disclose.
-
Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for New England Journal of Medicine: Journal Watch. Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Quintairos, Prieto, Wood & Boyer, PA. The institution of Dr. Kim has received research support from NIH/NCATS. The institution of Dr. Kim has received research support from NIH/NINDS. The institution of Dr. Kim has received research support from NIH/NIHMD. The institution of Dr. Kim has received research support from Patient-Centered Outcome Research Institute. The institution of Dr. Kim has received research support from American Heart Association. Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as a Speaker with American Neurological Association.
-
Dr. Gill has received personal compensation for serving as an employee of Sequoia Genetics Ltd. Dr. Gill has stock in Apollo Therapeutics. The institution of Dr. Gill has received research support from Medical Research Council.